Senior Director
Merck & Co.
Kenilworth, New Jersey, United States
Nicole completed a B.S. in Biology, with a biotechnology concentration at the University of Delaware and went on to complete a Ph.D. in synthetic organic chemistry at the University of California, Santa Cruz. She joined the Discovery Pharmaceutical Sciences department at Merck where she contributed to the nomination of multiple development compounds, implemented a Fixed Dose Combination workflow and led a novel excipient evaluation team. In 2018, Nicole transitioned to Sterile and Specialty Products and is a Senior Director of Biologics Development and Biopharmaceutics with a focus on the subcutaneous delivery of biologics. She is co-leading a multidepartment innovation team focused on understanding all aspects of subcutaneous product development. Nicole has been an active member of the IQ Consortium and co-chairs the Accelerated Drug Development Working Group within the Drug Product Leadership Group. She is a board member and co-chair of the Immunogenicity sub-team of the SC Consortium. Nicole is an active member of the AAPS community and served as the Excipient Focus Group Chair and serves in the Global Health Community. Nicole is a champion for Global Health and in 2014 was accepted as a fellow into a 3 month field-based assignment through the Merck Fellowship for Global Health.
Disclosure information not submitted.
Monday, April 24, 2023
9:00 AM – 9:30 AM ET